title: Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.
abstract: Estrogen receptor-alpha (ERα) is an important biomarker used to classify and direct therapy decisions in breast cancer (BC). Both ERα protein and its transcript, ESR1, are used to predict response to tamoxifen therapy, yet certain tumors have discordant levels of ERα protein and ESR1, which is currently unexplained. Cellular ERα protein levels can be controlled post-translationally by the ubiquitin-proteasome pathway through a mechanism that depends on phosphorylation at residue S118. Phospho-S118 (pS118-ERα) is a substrate for the peptidyl prolyl isomerase, Pin1, which mediates cis-trans isomerization of the pS118-P119 bond to enhance ERα transcriptional function. Here, we demonstrate that Pin1 can increase ERα protein without affecting ESR1 transcript levels by inhibiting proteasome-dependent receptor degradation. Pin1 disrupts ERα ubiquitination by interfering with receptor interactions with the E3 ligase, E6AP, which also is shown to bind pS118-ERα. Quantitative in situ assessments of ERα protein, ESR1, and Pin1 in human tumors from a retrospective cohort show that Pin1 levels correlate with ERα protein but not to ESR1 levels. These data show that ERα protein is post-translationally regulated by Pin1 in a proportion of breast carcinomas. As Pin1 impacts both ERα protein levels and transactivation function, these data implicate Pin1 as a potential surrogate marker for predicting outcome of ERα-positive BC.
authors.affiliation: Department of Oncology, UW Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
authors.forename: P
authors.initials: P
authors.lastname: Rajbhandari
authors.affiliation: Department of Pathology, Yale University Medical School, New Haven, CT, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Schalper
authors.affiliation: Department of Oncology, UW Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
authors.forename: N M
authors.initials: NM
authors.lastname: Solodin
authors.affiliation: Department of Oncology, UW Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Ellison-Zelski
authors.affiliation: Department of Medicine, Cancer Biology Program, Beth Isreal Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Ping Lu
authors.affiliation: Department of Pathology, Yale University Medical School, New Haven, CT, USA.
authors.forename: D L
authors.initials: DL
authors.lastname: Rimm
authors.affiliation: Department of Oncology, UW Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
authors.forename: E T
authors.initials: ET
authors.lastname: Alarid
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism*; D045744:Cell Line, Tumor; D047628:Estrogen Receptor alpha / Q000378:metabolism*; D005260:Female; D006801:Humans; D000072340:NIMA-Interacting Peptidylprolyl Isomerase; D019696:Peptidylprolyl Isomerase / Q000502:physiology*; D010766:Phosphorylation; D059748:Proteolysis; D054875:Ubiquitination
chemical_list: D047628:Estrogen Receptor alpha; D000072340:NIMA-Interacting Peptidylprolyl Isomerase; C000606846:PIN1 protein, human; D019696:Peptidylprolyl Isomerase
references.citation: Mol Cell Biol. 2005 Jul;25(13):5417-28
references.pmid: 15964799
references.citation: Mol Endocrinol. 2003 Oct;17(10):2013-27
references.pmid: 12855746
references.citation: Nat Rev Mol Cell Biol. 2007 Nov;8(11):904-16
references.pmid: 17878917
references.citation: J Biochem. 2009 Mar;145(3):331-43
references.pmid: 19122208
references.citation: Nature. 1999 Jun 24;399(6738):784-8
references.pmid: 10391244
references.citation: Cell. 1997 Jun 13;89(6):875-86
references.pmid: 9200606
references.citation: J Cell Biol. 2008 Oct 6;183(1):49-61
references.pmid: 18838553
references.citation: Nat Med. 2002 Nov;8(11):1323-7
references.pmid: 12389040
references.citation: J Biol Chem. 2003 Feb 14;278(7):4639-45
references.pmid: 12466266
references.citation: Endocrinology. 2011 Jun;152(6):2517-26
references.pmid: 21505052
references.citation: Nat Cell Biol. 2001 Sep;3(9):793-801
references.pmid: 11533658
references.citation: J Biol Chem. 2010 Jan 29;285(5):3126-32
references.pmid: 19996102
references.citation: Mol Cell. 2012 Jun 29;46(6):771-83
references.pmid: 22608923
references.citation: Nat Chem Biol. 2007 Oct;3(10):619-29
references.pmid: 17876319
references.citation: Mol Cell Biol. 2012 Jan;32(2):445-57
references.pmid: 22064478
references.citation: Mol Endocrinol. 2008 Feb;22(2):317-30
references.pmid: 17962381
references.citation: Endocrinology. 2005 Apr;146(4):1707-12
references.pmid: 15691896
references.citation: EMBO J. 2001 Jul 2;20(13):3459-72
references.pmid: 11432833
references.citation: Mol Cell. 2000 Oct;6(4):873-83
references.pmid: 11090625
references.citation: Mol Cell. 2006 Jan 20;21(2):295-305
references.pmid: 16427018
references.citation: Cancer Res. 2007 Jun 1;67(11):5513-21
references.pmid: 17545634
references.citation: Cell. 1989 Nov 3;59(3):477-87
references.pmid: 2805068
references.citation: Nucl Recept Signal. 2008 Apr 18;6:e006
references.pmid: 18432313
references.citation: Mol Cell. 2003 Dec;12(6):1413-26
references.pmid: 14690596
references.citation: Trends Cell Biol. 2002 Apr;12(4):164-72
references.pmid: 11978535
references.citation: Biomed Pharmacother. 2006 Nov;60(9):520-8
references.pmid: 16949786
references.citation: Mol Cell. 2004 Jun 4;14(5):625-36
references.pmid: 15175157
references.citation: J Clin Oncol. 2010 Jan 20;28(3):509-18
references.pmid: 19949017
references.citation: Cell. 1987 Dec 24;51(6):941-51
references.pmid: 3690665
references.citation: Cancer Res. 2005 Feb 1;65(3):681-5
references.pmid: 15705859
references.citation: Mol Cell Proteomics. 2009 Mar;8(3):467-80
references.pmid: 18984578
references.citation: Mol Cell Biol. 2012 May;32(10):1928-43
references.pmid: 22431515
references.citation: Breast Cancer Res. 2003;5(2):76-82
references.pmid: 12631385
references.citation: Leukemia. 2010 May;24(5):914-23
references.pmid: 20376080
references.citation: Lancet. 2005 May 14-20;365(9472):1687-717
references.pmid: 15894097
references.citation: Mol Endocrinol. 2012 Sep;26(9):1567-77
references.pmid: 22865929
references.citation: FASEB J. 2004 Jan;18(1):81-93
references.pmid: 14718389
references.citation: EMBO J. 2004 Aug 18;23(16):3397-407
references.pmid: 15257284
references.citation: Endocrinology. 2007 Oct;148(10):4634-41
references.pmid: 17615152
references.citation: Mol Cell. 2003 Mar;11(3):695-707
references.pmid: 12667452
references.citation: Biochem Biophys Res Commun. 2007 May 25;357(1):245-51
references.pmid: 17418098
references.citation: J Natl Cancer Inst. 1998 Jan 7;90(1):37-42
references.pmid: 9428781
references.citation: J Clin Oncol. 2011 Aug 1;29(22):2978-84
references.pmid: 21709197
references.citation: Oncogene. 2012 Aug 23;31(34):3845-56
references.pmid: 22158035
references.citation: Nat Cell Biol. 2005 May;7(5):435-41
references.pmid: 15867923
references.citation: Mol Endocrinol. 2006 Feb;20(2):291-301
references.pmid: 16179380
references.citation: Oncogene. 2012 Jun 7;31(23):2876-87
references.pmid: 22002310
references.citation: J Clin Oncol. 2011 Nov 1;29(31):4160-7
references.pmid: 21947828
references.citation: Lancet Oncol. 2007 Mar;8(3):203-11
references.pmid: 17329190
references.citation: Mol Cell. 2000 Jun;5(6):939-48
references.pmid: 10911988
references.citation: Oncogene. 1997 Dec 18;15(25):3037-46
references.pmid: 9444952
references.citation: J Biol Chem. 2002 Dec 13;277(50):47976-9
references.pmid: 12388558
references.citation: Nat Rev Mol Cell Biol. 2003 Mar;4(3):192-201
references.pmid: 12612638
references.citation: Cancer Res. 2006 Sep 15;66(18):9308-15
references.pmid: 16982776
references.citation: EMBO J. 2004 Dec 8;23(24):4813-23
references.pmid: 15538384
references.citation: J Biol Chem. 2010 Jul 30;285(31):23829-41
references.pmid: 20479004
references.citation: Biochemistry. 1998 Apr 28;37(17):5953-60
references.pmid: 9558330
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5794-9
references.pmid: 17392432
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: PLoS One. 2012;7(5):e36559
references.pmid: 22606272
references.citation: Cell Signal. 2003 Apr;15(4):355-66
references.pmid: 12618210
references.citation: Nature. 2002 Oct 24;419(6909):849-53
references.pmid: 12397361
references.citation: J Steroid Biochem Mol Biol. 1994 Mar;48(4):325-36
references.pmid: 8142311
references.citation: Mol Endocrinol. 2006 Sep;20(9):1972-81
references.pmid: 16423879
references.citation: Science. 1997 Dec 12;278(5345):1957-60
references.pmid: 9395400
references.citation: J Biol Chem. 2009 Sep 4;284(36):23980-8
references.pmid: 19584057
references.citation: Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1335-40
references.pmid: 11805292
references.citation: Mol Cell Biol. 2009 Sep;29(18):4949-58
references.pmid: 19620290
references.citation: Cancer Res. 2007 Nov 1;67(21):10582-91
references.pmid: 17975003
references.citation: Breast Cancer Res Treat. 2012 Feb;132(1):97-108
references.pmid: 21553290
references.citation: Steroids. 2003 Jan;68(1):1-9
references.pmid: 12475718
references.citation: J Biol Chem. 2006 Jan 27;281(4):1978-85
references.pmid: 16314411